Blood Platelets Market Share

  • Report ID: 4719
  • Published Date: Jul 31, 2024
  • Report Format: PDF, PPT

Blood Platelets Market Share

North American Market Forecast

The blood platelets market in the North America region is predicted to dominate the market with a share of 35 % during the time period between 2023 – 2036. The growth of the market in this region is primarily driven by the increased demand for blood transfusion, followed by the rising number of accidents. As per the U.S. Department of Transportation, the number of people who died in motor vehicle traffic crashes increased to 9,560 in the first quarter of 2022. Furthermore, in the North America region, several countries have been experiencing economic growth which is expected to contribute to the increased healthcare spending and demand for advanced medical treatments.

APAC Market Statistics

The Asia Pacific region market for blood platelets is estimated to experience significant market expansion with a revenue of 28 percent by the end of the predicted period. The growth of this sector is driven on the back of several factors such as a high number of the presence of bleeding disorder, especially in emerging economies such as India and China. Besides, the growing number of trauma cases and advancement in healthcare infrastructure in the region are raising awareness related to blood donation in the Asia Pacific region. Blood donation in China grew by more than 40 percent between 1998 and 2020 due to growing awareness.

Research Nester
Blood Platelets Market Size
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4719
  • Published Date: Jul 31, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of blood platelets is assessed at USD 5.57 Billion.

The blood platelets market size was over USD 5.39 Billion in 2023 and is likely to reach USD 8.65 Billion by the end of 2036, growing at around 3.7% CAGR during the forecast period i.e., between 2024-2036. The increasing prevalence of blood-related disease and the increasing geriatric population is estimated to boost the market growth.

North America region is predicted to hold at 35% of the revenue share by 2036, driven by increased demand for blood transfusion along with rising number of accidents in the region.

Aggredyne Inc., Sysmex Corporation, Haemochrom Diagnostics GmbH, Eurobio Scientific, LABiTec Labor BioMedical Technologies GmbH, Thermo Fisher Scientific Inc., PerkinElimer Inc., Werfen, S.A., F. Hoffmann-La Roche Ltd., Terumo Corporation
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample